Home > Journals > Minerva Psichiatrica > Past Issues > Minerva Psichiatrica 2002 June;43(2) > Minerva Psichiatrica 2002 June;43(2):77-84

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA PSICHIATRICA

A Journal on Psychiatry, Psychology and Psychopharmacology


Official Journal of the Italian Society of Social Psychiatry
Indexed/Abstracted in: EMBASE, e-psyche, PsycINFO, Scopus, Emerging Sources Citation Index


eTOC

 

ORIGINAL ARTICLES  


Minerva Psichiatrica 2002 June;43(2):77-84

Copyright © 2002 EDIZIONI MINERVA MEDICA

language: Italian

Six-months tolerability of SSRIs treatment

Berardi S., Maina G., Bogetto F.


PDF  


Background. SSRIs represent an important advance in the pharmacotherapy of mood and the other disorders. Although the safety of SSRIs is higher than tricyclic antidepressants (TCA) they have side effects that should be considered. The aim of this study is to describe the prevalence of side effects during a six-months treatment with SSRIs in a population of 266 outpatients with diagnosis of mood disorder.
Methods. Two hundred and sixty-six outpatients with mood disorder were consecutively investigated. Patients were interviewed with a semistructured clinical interview for the assessment of demographic data, pharmachological therapy, side effects during six months treatment, weight, height, BMI. The following rating scale were included: Hamilton rating scale for depression (HAM-D) and Hamilton rating scale for anxiety (HAM-A).
Results. SSRIs present side effects and their prevalence in this study is in agreement with literature data.
Conclusions. Even if adverse events are a problem for patients' compliance, SSRIs are significantly better tolerated than tricyclic antidepressants and there are no differences in efficacy between these two classes of antidepressants.

top of page

Publication History

Cite this article as

Corresponding author e-mail